Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:54:02.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed descriptions of a clinical study on Advanced Soft Tissue Sarcoma and the addition of a new version revision. The study's core details, such as the specific treatment protocols and eligibility criteria, have been deleted, which may impact the understanding of the study's scope and requirements.
    Difference
    42%
    Check dated 2025-04-16T01:46:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added indicating February 24, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.3%
    Check dated 2025-04-08T20:28:24.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:00:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The study has shifted from focusing on first-line treatment to previously treated patients for both Phase 1 and Phase 2 parts, and the timeline for the study has been updated with new dates. Additionally, the study's title and details have been revised to reflect these changes.
    Difference
    6%
    Check dated 2025-03-03T22:24:03.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:50:32.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.